Hepatobiliary and Pancreatic Diseases International

Aims & Scope

Hepatobiliary & Pancreatic Diseases International (HBPD INT) (ISSN 1499-3872 / CN 33-1391/R), owned by the First Affiliated Hospital, Zhejiang University School of Medicine in China, publishes peer-reviewed original papers, reviews and editorials concerned with clinical practice and research in the fields of hepatobiliary and pancreatic diseases.

Papers cover the medical, surgical, radiological, pathological, biochemical, physiological and histological aspects of the subject areas under the headings Liver, Biliary, Pancreas, Transplantation, Research, Special Reports, Editorials, Review Articles, Brief Reports, Clinical Summary, New Techniques, and Clinical Images.

The journal also deals with the basic sciences and experimental work.

All submitted papers are reviewed by at least two referees expert in the field of the submitted paper.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.4

SJR (SCImago Journal Rank)

Year	Value
2024	0.964

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	59

Journal Rank

Year	Value
2024	5143

Journal Citation Indicator

Year	Value
2024	747

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease

  Citation: 470

  Authors: Feng, Rui-Dan, Xing-Qiang, Wen-Jin, Xiao-Ying, Jian-Gao

• Inflammatory response of macrophages in infection

  Citation: 157

  Authors: Ling, Cheng-Cai

• Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets

  Citation: 132

  Authors: Devaraj, Etienne, Mustapha

• Pathophysiological consequences of obstructive jaundice and perioperative management

  Citation: 123

  Authors: Efstathios T, Theodoros E

• Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathway

  Citation: 122

  Authors: Lei, Fu-Bao, Mei, Kun, Qing-Song, Chen-Hai, Min-Jing, Qiang

• Predictive value of C-reactive protein/albumin ratio in acute pancreatitis

  Citation: 118

  Authors: Mustafa, Ihsan, Muhammed Yener, Mahmut, Ufuk Baris, Sabite, Orhan, Ertugrul

• Severe acute pancreatitis: pathogenesis, diagnosis and surgical management

  Citation: 108

  Authors: Mark, Christopher David

• Primary graft dysfunction after liver transplantation

  Citation: 108

  Authors: Xiao-Bo, Ming-Qing

• Augmented reality technology for preoperative planning and intraoperative navigation during hepatobiliary surgery: A review of current methods

  Citation: 103

  Authors: Rui, Long-Fei, Zhi-Xia, Mo-Dan, Jian-Ping, Xue-Dong, Hong-En, Jia-Hong

• Changes of gut bacteria and immune parameters in liver transplant recipients

  Citation: 99

  Authors: Zhong-Wen, Zong-Xin, Hai-Feng, Jian, Ji-Fang, Shu-Sen, Lan-Juan

---